Nurix Therapeutics Pulls In $120M Posted by dumbcapital | Mar 17, 2020 | Raises and Exits, Uncategorized | 0 | SAN FRANCISCO, CA, Nurix Therapeutics, a company developing targeted protein modulation drugs, today announced it has closed an oversubscribed $120 million financing.